INTRODUCTION
Adenomyoepithelioma (AME) of the breast is an uncommon tumor characterized by dual epithelial and smooth muscle differentiation of tumor cells [1] . Breast tumors with myoepithelial differentiation are rare but in salivary glands, more common. Sarkar and Lallenbach [2] were first described about various amounts of myoepiepithelial cells with the degree of differentiation of various breast tumors in 1966. Hamperl [3] was first reported to AME of the breast in 1970. According to many reports up to the present, it can demonstrate pure myoepithelial or epi-myoepithelial differentiation of benign and malignant breast tumors [1] [2] [3] . Most of the myoepithelioma or AME have been considered to be benign.
However, malignant transformation of tumor is characterized by infiltrating tumor margins, atypical cytologic change, brisk of mitotic figures, tumor necrosis and rarely can be distantly metastasized.
According to World Health Organization, myoepithelial lesions of the breast can be classified as myoepitheliosis, adenomyoepithelial adenosis, AME and malignant myoepithelioma (Table 1) [4] . We report herein on a case of synchronous myoepithelial carcinoma arising in thesurgery.or.kr 
CASE REPORT
A 51-year-old woman presented a re-growing remnant Fig. 2A) . At the high power field of light microscopy, the atypical tumor cells showed round to spindle, hyperchromatic and pleomorphic nuclei with rel- atively abundant eosinophilic cytoplasm (Fig. 2B) . Atypical mitotic figures were easily found throughout the tumor and up to 8 mitoses were counted in 10 high-power fields (Fig. 2C) . The right breast mass consisted of small clusters of tumor cells within the clear stromal spaces (Fig.   2D ).
Immunohistochemically, spindle tumor cells were diffusely positive for smooth muscle actin (Fig. 3A) , calponin (Fig. 3B), p63 (Fig. 3C) and pancytokeratin (Fig. 3D) . The labeling index of Ki-67 at the peripheral portion of mass was more than 40%. On the basis of the histological and immunohistochemical results, we considered this case as a synchronous myoepithelial carcinoma arising in AME and invasive micropapillary carcinoma in both breasts.
DISCUSSION
AME of the breast is characterized by microscopically biphasic proliferation of epithelial and myoepithelial cells.
The AME of breast is a very rare tumor that was already reported in 1970 [3] . The majority of AME are benign, but malignant transformation may occur in AME. Both benign and malignant AME are inclined to local recurrence after surgery and may even recur several years after the initial surgery [5, 6] . The guidelines of malignant AME have been thesurgery.or.kr not established yet. However we can use the term 'malignant AME' that has infiltrating margins, markedly increased mitotic counts and distinctly cytologic atypia in case of not having definite metastasizing evidence [7] .
Also distant metastasis and local recurrence are the most obvious evidences of malignancy. Subsequently, malignant transformation of AME can be divided into three different types according to the main malignant cell types: 1) completely epithelial type; 2) malignant spindle cell type; and outer myoepithelial cells which could be diagnosed with AME. Consequently, our case is a myoepithelial carcinoma arising in AME. Interestingly, in our case, a contralateral invasive micropapillary carcinoma was found.
Han et al. [8] researched molecular abnormalities of malignant AME and reported the point mutation of p53 gene in this myoepithelial cells, but not in intraluminal epithelial cells or adjacent normal ductal epithelium. Also Jones et al. [9] were performed comparative genomic hybridization (CGH) analysis on a malignant AME case in another study. Furthermore, Angèle et al. [10] have also reported that p53 protein was negative in benign myoepithelial lesions but overexpressed in 44.4% of malignant myoepithelial tumors of the breast. Recently some molecular studies of AME have been trying to identify the molecular pathway of tumorigenesis of AME, but due to the rarity of AME or malignant AME, the pathway has not been established yet.
In conclusion, our case is a rare case of myoepithelial carcinoma arising in AME with contralateral invasive micropapillary carcinoma. Despite the definite diagnosis of malignant AME can be possible throughout various immunohistochemistry, pathologists who are unaware of myoepithelial lesions can make a misdiagnosis of malignant AME. Finally, in case of malignant AME or malignant myoepithelial tumors, close follow up and in some cases, adequate further treatment with adjuvant chemotherapy or radiotherapy should be considered.
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